NOS3 and Hypertension: Our group demonstrated that CST-Ser diminishes endothelial nitric oxide synthase activity, and causes a concomitant decrease in endothelial NO production, as compared to CST-WT, thereby conferring a higher risk of hypertension to the carriers of this genotype [11].